Paula A Lengerke-Diaz
3PUBLICATIONS
16CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (3)
Sort by Publication Date:
|Feb 01, 2022
Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after Ibrutinib Discontinuation: A Single-Arm, Open-Label, Phase 1b/2 Clinical Trial NCT0231576.Januario E Castro, Paula A Lengerke-Diaz, Juliana Velez Lujan
|Sep 07, 2021
Validation of VIRSTA and Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT) Scores to Determine the Priority of Echocardiography in Patients With Staphylococcus aureus Bacteremia.Juan Sebastián Peinado-Acevedo, Juan José Hurtado-Guerra, Carolina Hincapié
Pageof 1
Frequent Collaborators
2 joint publications
Eider F Moreno-Cortes
2 joint publications
Jose V Forero Forero
2 joint publications
Januario E Castro
1 joint publications
Nanxi Yu
1 joint publications
Ryan M Porter
1 joint publications
Xinyu Zhou
1 joint publications
Wenwen Jing
1 joint publications
Fenni Zhang
1 joint publications
Erica Forzani
1 joint publications
Shaopeng Wang